Roche & European Union

Roche: Roche received IVDR approval for its VENTANA MMR RxDx Panel, expanding its use across multiple cancer types and therapies, which is a positive development for the company's diagnostics division and market position.

European Union: The European Union's In Vitro Diagnostic Regulation (IVDR) provided the regulatory framework for the approval of the VENTANA MMR RxDx Panel, enabling its availability in member countries.

Roche: Roche, a major Swiss corporate giant, rejects the initiative, stating it would threaten agreements with the European Union and worsen the shortage of skilled workers.

European Union: The European Union's free movement agreement with Switzerland is directly threatened by the proposed population cap, which could damage trade relations and access to the single market.

Roche: Roche is a key partner in the urgent high-level coordination meeting convened by United States — Centers for Disease Control and Prevention, potentially involved in assessing medical countermeasures for the Ebola outbreak.

European Union: The European Union considers the risk to its general public very low but has begun coordinating laboratory preparedness and traveler guidance through its Health Security Committee.

Roche: Roche's vice chair, André Hoffmann, is a co-chair of the World Economic Forum annual meeting.